Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 24,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppd.com.
Language:
English
Who can attend? Everyone
Featured Presenters
Global VP, Cell and Gene Therapy Strategy Lead
As a senior-level industry executive in prior CMO roles and a cancer immunotherapy expert, Dr. Theocharous has led multiple hematology/oncology assets in clinical development including innovative immuno-oncology technologies (1st generation clinical CAR-T cell applications in hematologic malignancies, and AAV gene-directed therapies in benign disorders) and successful life cycle management, MAA/NDA and HTA submissions.
Global VP & Therapeutic Area Head, Rare Diseases and Pediatrics
Timothy leads PPD’s pediatrics and rare disease functions in global product development. He joined PPD in 2018 with more than 20 years of healthcare experience in academic medical
centers and the pharmaceutical and biotech industries. His research interests encompass neurologic and orphan diseases, genetic and neuromuscular disorders, and inflammatory/immune-mediated diseases of the nervous system.
centers and the pharmaceutical and biotech industries. His research interests encompass neurologic and orphan diseases, genetic and neuromuscular disorders, and inflammatory/immune-mediated diseases of the nervous system.
Senior Director, Bioanalytical Laboratories
Heather serves as Senior Director of R&D, Immunochemistry at PPD leading a group of scientists responsible for bioanalytical and biomarker method development, validation and automation supporting gene and cell therapies, biosimilars and novel biologics.
Associate Director, Marketing, Global Conferences
Over 17 years of B2B and corporate marketing event experience managing global conferences and tradeshows in CRO and Healthcare IT industries.
VP, Precision and Transformative Medicine
Focused on strategic value demonstration, market access/reimbursement and commercial planning and work to link core clinical, regulatory, HEOR and access services to ensure successful development and launch of cell and gene therapies.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents